Acquiring Company
Barinthus Biotherapeutics plc
Acquired Company
Clywedog Therapeutics
Description
Barinthus Biotherapeutics is set to merge with Clywedog Therapeutics to form a new company focused on autoimmune and metabolic diseases. This merger is projected to provide a cash runway through 2027, enhancing research and development capacities.
Who to call at Barinthus Biotherapeutics plc, and when
When Barinthus Biotherapeutics plc changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Barinthus Biotherapeutics plc raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Barinthus Biotherapeutics plc, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Barinthus Biotherapeutics plc makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Clywedog Therapeutics?
Clywedog Therapeutics was acquired by Barinthus Biotherapeutics plc, based in Oxford. The deal was reported on March 13, 2026. Barinthus Bio is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. Barinthus Biotherapeutics plc is privately held and operates in Biotechnology.
When did Barinthus Biotherapeutics plc acquire Clywedog Therapeutics?
Barinthus Biotherapeutics plc's acquisition of Clywedog Therapeutics was reported on March 13, 2026. Barinthus Biotherapeutics is set to merge with Clywedog Therapeutics to form a new company focused on autoimmune and metabolic diseases. This merger is projected to provide a cash runway through 2027, enhancing research and development capacities. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Clywedog Therapeutics do?
Clywedog Therapeutics is the company acquired in this transaction. It is privately held.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.